跳至主要内容
临床试验/ISRCTN07836779
ISRCTN07836779已完成不适用

OSTRADAMUS: testing for thrombophilia in patients with a first episode of venous thromboembolism: a randomised controlled trial to assess effects on clinical outcomes, quality of life, and costs

Academic Medical Center (AMC) (The Netherlands)0 个研究点目标入组 1,336 人开始时间: 2006年12月28日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,336

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Subjects must be willing and able to give written informed consent
  • 2. Confirmed symptomatic Deep Vein Thrombosis (DVT), i.e., proximal vein or extensive calf-vein
  • thrombosis, involving at least the upper third part of the deep calf veins (trifurcation, and/or confirmed symptomatic Pulmonary Embolism (PE), no longer than two months prior to randomisation
  • 3. Aged 18 years or older

排除标准

  • 1. Previous episodes of DVT or PE
  • 2. Active bleeding or high risk for bleeding contraindicating treatment with Low Molecular Weight Heparin (LMWH), fondaparinux or Vitamin K Antagonists (VKA)
  • 3. Insertion of a caval filter to treat the episode of VTE
  • 4. Active cancer or anti-cancer treatment in the six months prior to the acute episode of VTE
  • 5. Life expectancy less than 18 months
  • 6. Arterial thrombotic events in the context of a confirmed antiphospholipid antibody syndrome
  • 7. Indications for VKA other than DVT

研究者

发起方
Academic Medical Center (AMC) (The Netherlands)

相似试验

OSTRADAMUS: testing for thrombophilia in patients... | 临床试验